Medvok Pharmaceuticals Private Limited
Medvok Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2017 and based in Delhi, India. It was founded by Jay and Pawan. Medvok Pharmaceuticals Private Limited operates in Medical & Precision (NIC 33309) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2019-20, the company reported revenue of ₹5.78 L and a net loss of ₹93. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +27d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +13d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +36d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Medvok Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 865981915 | HDFC Bank Ltd(Bank) | ₹2.46 Cr | 04 Jul 2022 | Satisfied |
| 502653629 | State Bank of India(Bank) | ₹11.56 Cr | 04 Jul 2023 | Open |
| 988301637 | Kotak Mahindra Bank Ltd(Bank) | ₹21.08 Cr | 27 Jan 2020 | Satisfied |
| 903908926 | ICICI Bank Ltd(Bank) | ₹14.96 Cr | 19 Sep 2021 | Open |
| 822043352 | State Bank of India(Bank) | ₹6.30 Cr | 19 Sep 2022 | Satisfied |
| 894257440 | Axis Bank Ltd(Bank) | ₹10.46 Cr | 19 Sep 2023 | Satisfied |
Charge IDs, lenders & amounts for Medvok Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2019-20 | — | ||||
| 2017-18 | — |
Detailed Financials
2 FYs| Line item | 2019-20 | 2017-18 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2019-20 | +722.0% | — | — | |
| Profit after Tax2019-20 | — | — | — | |
| Net Worth2019-20 | -877.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | -1.65% | — | -4.14% | -1.85% | 2.24 | |||
| 2019-20 | -0.02% | +146.23% | — | -0.03% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,17,55,901 | 86.47% |
| Institutional Investors | 3 | 16,44,721 | 6.54% |
| Public & Others | 26 | 17,59,338 | 6.99% |
Promoter, institutional & public holding for Medvok Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
149 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.